Hisashi Hosaka

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

Wasaburo Koizumi, Yeul Hong Kim, Masashi Fujii et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 179 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: A randomised phase III trial (TCOG GI-0801/BIRIP trial)

Katsuhiko Higuchi, Satoshi Tanabe, Ken Shimada et al. · European Journal of Cancer · 2014 · 82 citations

Medicine, Oncology, Pharmacology +11

S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial

Yoon‐Koo Kang, Keisho Chìn, Hyun Cheol Chung et al. · The Lancet Oncology · 2020 · 77 citations · Full text

Medicine, Oncology, Pharmacology +11

Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study

Akihito Kawazoe, Kensei Yamaguchi, Hisateru Yasui et al. · European Journal of Cancer · 2020 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16

Irinotecan Plus Cisplatin for Therapy of Small-cell Carcinoma of the Esophagus: Report of 12 Cases from Single Institution Experience

K. Chin, S. Baba, Hisashi Hosaka et al. · Japanese Journal of Clinical Oncology · 2008 · 49 citations · Full text

Medicine, Oncology, Chemotherapy +8